Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors
In recent years, the incidence of various types of tumors has gradually increased, and it has also been found that there is a certain correlation between abnormal glucose and lipid metabolism and tumors. Glycolipid metabolism can promote tumor progression through multiple pathways, and the expressio...
Guardado en:
Autores principales: | Xianhu Zeng, Zhipeng Li, Chunrong Zhu, Lisa Xu, Yong Sun, Shangcong Han |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14bb6a3ee1f946eeb3d445ba20ca82ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer’s patch targeting approach
por: Prajapati JB, et al.
Publicado: (2018) -
Extracellular Vesicles – Advanced Nanocarriers in Cancer Therapy: Progress and Achievements
por: Huyan T, et al.
Publicado: (2020) -
Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer
por: Liang Y, et al.
Publicado: (2017) -
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Gustavo Henrique Rodrigues da Silva, et al.
Publicado: (2021) -
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
por: Din FU, et al.
Publicado: (2017)